Boston Scientific Other Non-Current Liabilities increased by 0.6% to $2.41B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 28.6%, from $1.87B to $2.41B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows relatively stable performance with a 0.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Significant changes may reflect shifts in lease accounting, changes in employee benefit plans, or the emergence of long-term legal risks.
A catch-all category for long-term obligations that do not fall into major classifications like debt or deferred taxes....
Varies significantly by industry; companies with large physical retail footprints often show higher values here due to long-term leases.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.19B | $2.30B | $2.22B | $2.00B | $1.99B | $1.92B | $2.04B | $2.00B | $1.93B | $1.86B | $1.97B | $1.92B | $1.80B | $1.84B | $1.87B | $1.95B | $2.38B | $2.39B | $2.41B |
| QoQ Change | — | +4.8% | -3.3% | -9.9% | -0.6% | -3.6% | +6.2% | -2.0% | -3.5% | -3.5% | +5.9% | -2.4% | -6.2% | +2.3% | +1.6% | +4.1% | +22.5% | +0.3% | +0.6% |
| YoY Change | — | — | — | — | -9.2% | -16.6% | -8.3% | -0.3% | -3.1% | -3.0% | -3.3% | -3.8% | -6.5% | -0.9% | -4.9% | +1.4% | +32.4% | +29.8% | +28.6% |